|
|
Article: Biotech Holdings Sucanon drug facility on schedule for completion.
- Article from:
- PR Newswire
- Article date:
- March 19, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-VEN: BIO.V; OTCBB: BIOHF) announced that the Company is on schedule for completing work at its Sucanon drug production facility.
"We have acquired all of the pharmaceutic processing machinery and equipment necessary for the production of Sucanon active ingredients and are progressing as planned with installation and related work at our production facility. We are planning for the facility to be ready for production as of the end of March," Mr. Rieveley said.
"Inventory is now being ordered for production of the active ingredients for Sucanon, with Sucanon production being initiated in ...
Related newspaper, magazine, and journal articles:
|
|
Article: Biotech Holdings expands distribution of its ...
PR Newswire;
May 30, 2007 ;
700+ words
... ... subject line. CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 ... background information on Biotech Holdings, or to receive news ... biotechltd.com/ CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 ...
|
|